Sunshine Biopharma (SBFM) Current Taxes (2022 - 2026)
Sunshine Biopharma (SBFM) posted Current Taxes of $268276.0 for Q1 2026, little changed on a QoQ basis from $268276.0 in Q4 2025, and up 17.61% year-over-year from $228115.0 in Q1 2025.
Sunshine Biopharma (SBFM) Current Taxes (2022 - 2026) Analysis & Trends
Sunshine Biopharma's Current Taxes history runs 5 years deep, the most recent figure standing at $268276.0 for Q1 2026.
- Quarterly Current Taxes rose 17.61% year-over-year to $268276.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268276.0 (up 17.61% YoY) and the FY2025 annual result came in at $268276.0, changed 0.0% from the prior year.
- Current Taxes was $268276.0 for Q1 2026 at Sunshine Biopharma, roughly flat from $268276.0 in the prior quarter.
- Across five years, Current Taxes topped out at $416245.0 in Q1 2023 and bottomed at $201541.0 in Q3 2023.
- A 5-year average of $275187.8 and a median of $258158.0 in 2025 frame the typical range for Current Taxes.
- Peak annual rise in Current Taxes reached 26.51% in 2024, while the deepest fall reached 38.74% in 2024.
- Sunshine Biopharma's Current Taxes stood at $373191.0 in 2022, then fell by 19.65% to $299869.0 in 2023, then decreased by 10.54% to $268276.0 in 2024, then changed by 0.0% to $268276.0 in 2025, then changed by 0.0% to $268276.0 in 2026.
- Business Quant data shows SBFM's Current Taxes at $268276.0 in Q1 2026, $268276.0 in Q4 2025, and $258158.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 268,276.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,276.00 |
| Dec 31, 2025 | 268,276.00 |
| Jun 30, 2025 | 258,158.00 |
| Mar 31, 2025 | 228,115.00 |
| Dec 31, 2024 | 268,276.00 |
| Sep 30, 2024 | 254,971.00 |
| Jun 30, 2024 | 254,971.00 |
| Mar 31, 2024 | 254,971.00 |
| Dec 31, 2023 | 299,869.00 |
| Sep 30, 2023 | 201,541.00 |
| Jun 30, 2023 | 230,581.00 |
| Mar 31, 2023 | 416,245.00 |
| Dec 31, 2022 | 373,191.00 |